方法对比
并排查看您选择的方法；存在差异的行会高亮显示。
| CHA₂DS₂-VASc 评分× | Wells DVT评分× | |
|---|---|---|
| 领域 | 临床评估 | 临床评估 |
| 方法族 | Process / pipeline | Process / pipeline |
| 起源年份≠ | 2010 | 1994 |
| 提出者≠ | Gregory Y. H. Lip, Robby Nieuwlaat, et al. | Philip S. Wells |
| 类型≠ | Atrial fibrillation stroke risk stratification | Venous thromboembolism risk stratification |
| 开创性文献≠ | Lip, G. Y., Nieuwlaat, R., Pisters, R., Lane, D. A., & Crijns, H. J. (2010). Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest, 137(2), 263-272. DOI ↗ | Wells, P. S., Hirsh, J., Anderson, D. R., et al. (1994). A simple clinical model for the diagnosis of deep-vein thrombosis combined with impedance plethysmography. Archives of Internal Medicine, 154(13), 1541-1546. link ↗ |
| 别名 | CHA2DS2VASc, Atrial fibrillation stroke risk | Wells DVT Score, DVT Wells |
| 相关 | 3 | 3 |
| 摘要≠ | The CHA₂DS₂-VASc score, developed by Lip, Nieuwlaat, and colleagues in 2010, is a 9-point risk stratification tool for predicting annual stroke and systemic thromboembolism risk in patients with atrial fibrillation. It is the recommended score by major cardiology guidelines for guiding anticoagulation decisions. | The Wells score, developed by Wells et al. in 1994, is a clinical prediction rule that stratifies patients into low, intermediate, or high pretest probability of deep vein thrombosis (DVT). It combines seven clinical features to guide diagnostic testing decisions and reduce unnecessary imaging in suspected DVT patients. |
| ScholarGate数据集 ↗ |
|
|